CPT2 and hyperinsulinemic hypoglycemia, familial, 4: On day 8 of life, she was identified as at-risk for CPT II deficiency or carnitine-acylcarnitine translocase (CACT) deficiency via expanded newborn screening using tandem mass spectrometry.